High FOXM1 expression is a prognostic marker for poor clinical outcomes in prostate cancer

Conclusions: In patients with PCa, high FOXM1 expression was associated with advanced tumor stages, high Gleason score, and poor prognosis. These data suggest a role of FOXM1 in biologically and clinically aggressive PCa.

Source: Journal of Cancer - June 13, 2019 Category: Cancer & Oncology Authors: Mee Young Kim, Ae Ryang Jung, Ga Eun Kim, Jonghyup Yang, U-Syn Ha, Sung-Hoo Hong, Yeong Jin Choi, Mi Hyoung Moon, Sae Woong Kim, Ji Youl Lee, Yong Hyun Park Tags: Research Paper Source Type: research